Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 2/20 | 0.53 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11036627 | 0.90 | EHMT1 (0.57) | AHCYEHMT1BCHERXFP1 | |
| SCHEMBL18950648 | 0.83 | BCHE (0.56) | AHCYEHMT1BCHE | |
| SCHEMBL14440981 | 0.82 | AHCY (0.49) | AHCYEHMT1RXFP1 | |
| SCHEMBL9851825 | 0.79 | EHMT1 (0.44) | AHCYEHMT1BCHERXFP1 | |
| SCHEMBL9851835 | 0.79 | EHMT1 (0.44) | AHCYEHMT1BCHERXFP1 | |
| SCHEMBL23619452 | 0.79 | BCHE (0.58) | AHCYBCHE | |
| SCHEMBL11416201 | 0.79 | BCHE (0.58) | AHCYBCHE | |
| SCHEMBL15395472 | 0.78 | AHCY (0.58) | AHCYEHMT1BCHE | |
| SCHEMBL15948883 | 0.78 | ADORA2A (0.56) | AHCYEHMT1 | |
| SCHEMBL20419166 | 0.78 | AHCY (0.58) | AHCYEHMT1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070185063-A1 | Seven-membered ring nucleosides | IDENIX PHARMACEUTICALS, INC. | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185063-A1 | Seven-membered ring nucleosides | NSUN2, NSUN3, HAVCR2 | AHCY 531/4885EHMT1 2870/4885BCHE 3255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.